Y2 Solution Archives

1 minute read

Luxa Biotechnology Appoints Dr. Keith Dionne as CEO to Lead Advanced RPESC Therapy Development

Key Highlights Dr. Keith Dionne appointed as CEO of Luxa Biotechnology. Luxa develops a novel RPESC therapy for…

October 4, 2024